Stem-Cell Transplantation
Autologous transplantation is an effective salvage treatment for recurrent HL
Published in Clinical Oncology Week, July 5th, 2004
"Our purpose was to study the risk factors associated with disease progression after high-dose chemotherapy followed by autologous stem cell transplantation in patients with recurrent or refractory Hodgkin's lymphoma (HL). We analyzed the long-term outcome of 184 patients with recurrent or refractory HL who underwent autologous hematopoietic stem cell transplantation," scientists in the United States report.
"At the time of transplantation," wrote U. Popat and coworkers, "82 patients were in first relapse or second remission, 46 patients were refractory to the primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Breast Cancer
Widely reported cognitive side effect of chemotherapy may be overestimated - Cancer Therapy
Report: Taxotere offers significant benefits for head and neck cancer patients - Cancer Therapy
Study: Oral Xeloda is equivalent IV chemo in adjuvant colon cancer - Abdominal Surgery
Surgical interdisciplinarity is needed for abdominal surgery - Androgen Deprivation Therapy
Positive ACAPODENE data presented at ASCO meeting - Bone Metastasis
Bone metastasis is an infrequent first sign solid tumor spread - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
